(VIANEWS) – Globus Medical (GMED), Amphastar Pharmaceuticals (AMPH), StoneCo (STNE) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Globus Medical (GMED)
111.4% sales growth and 4.21% return on equity
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue-based products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
Earnings Per Share
As for profitability, Globus Medical has a trailing twelve months EPS of $1.07.
PE Ratio
Globus Medical has a trailing twelve months price to earnings ratio of 47.87. Meaning, the purchaser of the share is investing $47.87 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.21%.
Yearly Top and Bottom Value
Globus Medical’s stock is valued at $51.22 at 11:22 EST, way below its 52-week high of $62.88 and way above its 52-week low of $43.39.
2. Amphastar Pharmaceuticals (AMPH)
19% sales growth and 23.55% return on equity
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin, a low molecular weight heparin to prevent and treat deep vein thrombosis; Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, a lyophilized powder for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency. The company also provides Amphadase, a bovine-sourced hyaluronidase injection to absorb and disperse other injected drugs; Epinephrine injection for the emergency treatment of allergic reactions; lidocaine jelly, an anesthetic product for urological procedures; lidocaine topical solution for various procedures; phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products for emergency use in hospital settings; morphine injection for use with patient controlled analgesia pumps; and lorazepam injection for surgery and medical procedures. In addition, it offers neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; and Isoproterenol hydrochloride injection for mild or transient episodes of heart block. Further, the company distributes recombinant human insulin active pharmaceutical ingredients (API) and porcine insulin API. It serves hospitals, care facilities, alternate care sites, clinics, and doctors' offices. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.
Earnings Per Share
As for profitability, Amphastar Pharmaceuticals has a trailing twelve months EPS of $2.6.
PE Ratio
Amphastar Pharmaceuticals has a trailing twelve months price to earnings ratio of 17.13. Meaning, the purchaser of the share is investing $17.13 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.55%.
Volume
Today’s last reported volume for Amphastar Pharmaceuticals is 296210 which is 40.42% below its average volume of 497206.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Amphastar Pharmaceuticals’s EBITDA is 3.86.
3. StoneCo (STNE)
12.7% sales growth and 7.6% return on equity
StoneCo Ltd. provides financial technology and software solutions to merchants and integrated partners to conduct electronic commerce across in-store, online, and mobile channels in Brazil. It distributes its solutions, principally through proprietary Stone Hubs, which offer hyper-local sales and services; and sells solutions to brick-and-mortar and digital merchants through sales team. The company served approximately 2.6 million clients primarily small-and-medium-sized businesses; and marketplaces, e-commerce platforms, and integrated software vendors. StoneCo Ltd. was founded in 2000 and is headquartered in George Town, the Cayman Islands.
Earnings Per Share
As for profitability, StoneCo has a trailing twelve months EPS of $0.63.
PE Ratio
StoneCo has a trailing twelve months price to earnings ratio of 26.71. Meaning, the purchaser of the share is investing $26.71 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.6%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 100% and 80%, respectively.
Sales Growth
StoneCo’s sales growth is 25.9% for the ongoing quarter and 12.7% for the next.
Earnings Before Interest, Taxes, Depreciation, and Amortization
StoneCo’s EBITDA is 2.54.
4. Western Alliance Bancorporation (WAL)
9% sales growth and 12.64% return on equity
Western Alliance Bancorporation operates as the bank holding company for Western Alliance Bank that provides various banking products and related services primarily in Arizona, California, and Nevada. It operates through Commercial and Consumer Related segments. The company offers deposit products, including checking, savings, and money market accounts, as well as fixed-rate and fixed maturity certificates of deposit accounts; demand deposits; and treasury management and residential mortgage products and services. It also offers commercial and industrial loan products, such as working capital lines of credit, loans to technology companies, inventory and accounts receivable lines, mortgage warehouse lines, equipment loans and leases, and other commercial loans; commercial real estate loans, which are secured by multi-family residential properties, professional offices, industrial facilities, retail centers, hotels, and other commercial properties; construction and land development loans for single family and multi-family residential projects, industrial/warehouse properties, office buildings, retail centers, medical office facilities, and residential lot developments; and consumer loans. In addition, the company provides other financial services, such as internet banking, wire transfers, electronic bill payment and presentment, funds transfer and other digital payment offerings, lock box services, courier, and cash management services. Further, it holds certain investment securities, municipal and non-profit loans, and leases; invests primarily in low-income housing tax credits and small business investment corporations; and holds certain real estate loans and related securities. Western Alliance Bancorporation was founded in 1994 and is headquartered in Phoenix, Arizona.
Earnings Per Share
As for profitability, Western Alliance Bancorporation has a trailing twelve months EPS of $6.54.
PE Ratio
Western Alliance Bancorporation has a trailing twelve months price to earnings ratio of 9.43. Meaning, the purchaser of the share is investing $9.43 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.64%.
Yearly Top and Bottom Value
Western Alliance Bancorporation’s stock is valued at $61.65 at 11:22 EST, way under its 52-week high of $70.23 and way above its 52-week low of $11.35.
Sales Growth
Western Alliance Bancorporation’s sales growth is negative 3.1% for the current quarter and 9% for the next.
Revenue Growth
Year-on-year quarterly revenue growth declined by 3.6%, now sitting on 2.56B for the twelve trailing months.
5. W&T Offshore (WTI)
8.7% sales growth and 80.35% return on equity
W&T Offshore, Inc., an independent oil and natural gas producer, engages in the acquisition, exploration, and development of oil and natural gas properties in the Gulf of Mexico. The company sells crude oil, natural gas liquids, and natural gas. W&T Offshore, Inc. was founded in 1983 and is headquartered in Houston, Texas.
Earnings Per Share
As for profitability, W&T Offshore has a trailing twelve months EPS of $0.11.
PE Ratio
W&T Offshore has a trailing twelve months price to earnings ratio of 24.09. Meaning, the purchaser of the share is investing $24.09 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 80.35%.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Mar 15, 2024, the estimated forward annual dividend rate is 0.04 and the estimated forward annual dividend yield is 1.51%.
6. MYR Group (MYRG)
7% sales growth and 15.02% return on equity
MYR Group Inc., through its subsidiaries, provides electrical construction services in the United States and Canada. It operates through two segments, Transmission and Distribution, and Commercial and Industrial. The company's Transmission and Distribution segment offers a range of services on electric transmission and distribution networks, and substation facilities, including design, engineering, procurement, construction, upgrade, maintenance, and repair services with primary focus on construction, maintenance, and repair to customers in the electric utility industry. Its services include construction and maintenance of high voltage transmission lines, substations, and lower voltage underground and overhead distribution systems, and renewable power facilities; and limited gas construction services, as well as emergency restoration services in response to hurricane, ice, or other storm related damages. This segment serves as a prime contractor to customers, such as investor-owned utilities, cooperatives, private developers, government-funded utilities, independent power producers, independent transmission companies, industrial facility owners, and other contractors. Its Commercial and Industrial segment provides services, such as design, installation, maintenance, and repair of commercial and industrial wiring; and installation of traffic networks, bridge, roadway, and tunnel lighting. This segment offers its services for airports, hospitals, data centers, hotels, stadiums, convention centers, renewable energy projects, manufacturing plants, processing facilities, waste-water treatment facilities, mining facilities, and transportation control and management systems. It serves general contractors, commercial and industrial facility owners, governmental agencies, and developers. MYR Group Inc. was founded in 1891 and is headquartered in Henderson, Colorado.
Earnings Per Share
As for profitability, MYR Group has a trailing twelve months EPS of $5.41.
PE Ratio
MYR Group has a trailing twelve months price to earnings ratio of 31.89. Meaning, the purchaser of the share is investing $31.89 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.02%.
Volume
Today’s last reported volume for MYR Group is 123928 which is 9.03% below its average volume of 136232.
